ISB News

‘1 in 1,000:’ Dr. Sean Gibbons Named Highly Cited Researcher for 2023

ISB Associate Professor Dr. Sean Gibbons

ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. 

“I am humbled and honored to receive this distinction, and I am proud of the Gibbons Lab for conducting timely, novel and interesting research that continues to be read and cited by our peers,” Gibbons said.

The Highly Cited Research list is generated annually by Clarivate, which says:

“Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.”

This is the second consecutive year Gibbons has earned this honor. 

Since joining ISB in 2018, Gibbons has contributed to more than 40 published articles including peer-reviewed papers, perspectives and pre-prints. His research has been covered by The New York Times, The Economist, FOX News, TIME, and beyond.

Gibbons is a subject matter expert of the human gut microbiome and is frequently contacted by journalists to provide expertise and context around the quickly changing field, especially as it relates to consumers. For example, he was cited in this Bloomberg Businessweek story examining Viome and the often questionable microbiome-wellness startup space, and in this Washington Post story showing that when it comes to weight gain, not all calories are created equal.

Follow Gibbons’ latest research and news on BlueSky or X (formerly Twitter), and watch him in action explaining the microbiome and its importance in the video below.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.